This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
In 2023, R&D Leverage Europe invested substantially in equipment and infrastructure to facilitate this development, including the purchase of IBM machines for mold validation and sampling.
This extension of capabilities marks a transformative moment for R&D Leverage Europe as it positions itself as a comprehensive solution provider in the IBM sector. With an unwavering commitment to innovation and customer satisfaction, the company sees immense potential within this demanding market segment.
"We are thrilled to announce our expansion into the injection blow mold sector," said James Ramsey, Managing Director of R&D Leverage Europe. "Our substantial investments and dedication to enhancing our technical capabilities underscore our commitment to meeting the evolving needs of our customers."
In anticipation of the increased demand for its services, R&D Leverage Europe will expand its technical team both through numbers, and expertise through intensive training. This strategic move ensures that the company remains at the forefront of IBM technology and is well-equipped to deliver cutting-edge solutions.
Employing over 80 dedicated professionals, R&D Leverage Europe operates from state-of-the-art facilities on its campus in Ashfield, Nottinghamshire, England, with a total area of 40,000 sq ft. As part of its expansion plans, the company is actively developing an adjacent 15,000-sq-ft facility to house a second Product Solutions Lab, initially housing two mold validation machines for the IBM sector.